AMN Healthcare Services Inc (AMN)

FairStock Score: 54/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach AMN as a healthcare workforce intermediary, not a hospital owner: it supplies nurses, allied staff and physician leaders. Scale and hospital relationships help, but staffing is competitive and cyclical, so I do not see a wide moat. The numbers show a business in recovery. Revenue fell from $3.8B in FY2023 (year ended 2023-12-31) to $3.0B in FY2024 (year ended 2024-12-31) and $2.7B in FY2025 (year ended 2025-12-31). Net income swung from $210.7M in FY2023 to losses of $147.0M in FY2024 and $95.7M in FY2025. FairStock labels it TURNAROUND — Loss in latest year after earlier profits. More recently, fiscal Q1 2026 (quarter ended 2026-03-31) produced net income of $62.2M, and fiscal Q2 2026 (quarter ended 2026-06-30) produced $21.2M on $673.2M revenue. That is progress, but Q2's 3.14% margin is thin.

In plain English: AMN Healthcare Services provides staffing and workforce services to hospitals and healthcare facilities. The business looks uneven: it lost money in fiscal 2024 and 2025 after a profitable 2023, but it has recently returned to quarterly profits and generates strong cash flow. At the 2026-10-13 close of $36.54, the price looks around fair to slightly expensive against its earnings and accounting value, though the cash generation makes it less clear-cut.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer